Stock Information
Enanta Pharmaceuticals Inc (ENTA)
Ticker Symbol: ENTA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $379.25 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -3.2044
Revenue (TTM): $2.33 M
Dividend Yield: N/A%
ROE: -78.59%
Latest News
-
Enanta Pharmaceuticals Inc Announces First Participant Dosed in Phase 1 Clinical Trial of Edp-978
Mon, Apr 13, 2026 2:55 PM
-
Enanta Pharmaceuticals Announced That The First Participant Has Been Dosed In A Phase 1 Clinical Trial Of EDP-978, An Oral, Once-daily Kit Inhibitor In Development For Urticaria And Other Mast Cell-driven Diseases
Mon, Apr 13, 2026 7:09 AM
-
Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria
Mon, Apr 13, 2026 7:01 AM
Key Financials
Financial data not available
